Echelon joins NIH Common Fund Resources List
Echelon Biosciences Inc. is pleased to join the NIH Glycoscience Common Fund Program listing of Companies w/ Glycoscience Catalogs. Echelon …
Echelon Biosciences Inc. is pleased to join the NIH Glycoscience Common Fund Program listing of Companies w/ Glycoscience Catalogs. Echelon …
Utah’s flourishing Life Sciences Industry was proudly on display at the 2023 Annual Life Sciences Day on Capitol Hill. Echelon …
Echelon Biosciences participates at Life Sciences Day with BioUtah Read More »
Echelon Biosciences Inc. (EBI) is excited to announce a new partnership with ProBioscience Technologies for product distribution in Singapore and …
November, 15, 2022 – Salt Lake City, UT, USA – Echelon Biosciences announces that it has been selected as the 2022 …
Echelon Biosciences selected as the 2022 Bioz “Rising Star” ELISA Winner Read More »
This year marks a major milestone for Echelon Biosciences (EBI). We are celebrating our 25th Anniversary as a company. EBI’s …
(Salt Lake City, UT and Paris, FR, April 13, 2021) – HTL, the worldwide leader in biotechnology solutions using hyaluronic …
HTL Biotechnology and Echelon Biosciences Inc. announce strategic partnership Read More »
Echelon Biosciences is proud to announce a new partnership with Biotechno Labs for product distribution in India. Based in New …
Echelon Biosciences partners with Biotechno Labs for distribution in India Read More »
A new SBIR grant through the Department of Defense aims to develop new prophylactic treatments for exposure to chemical warfare …
Spring 2019 Press Release Echelon now offers the follwing Hyalose products: Select-HA™ Select-HA™ is a hyaluronic acid (HA) preparation …
A $2.3 million Department of Defense grant will help neuroscientists develop new treatments for the emergency room and the battlefield. …